PATENT CLAIM ANALYSIS

Application Number: 15876821
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "04400R"]

Abstract:
Expression vectors and therapeutic methods of using such vectors in the treatment of diseases of the eye resulting from failure to produce a specific protein in the eye, or the production of a non-functional protein in the eye.

Claim (Index 14):
The method of  claim 12 , wherein the administration of the anti-inflammatory agent is initiated prior to the day of administration of the expression vector.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.53846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14766842', '14660657', '12366596', '13212078', '13388083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7242439843871363
- 35 USC 102 Novelty (BERT): 0.5756745961581008
- Combined Prediction Score: 0.7093870455642328
- Mean Citation Score: 352.866614
- Max Citation Score: 571.0919
- Similarity Product: 317.9584445886373

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test